PPE Request
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 1S10AI162135-01
Grant search
Key facts
Disease
COVID-19Start & end year
20212022Known Financial Commitments (USD)
$373,601Funder
National Institutes of Health (NIH)Principal Investigator
Karen KeslerResearch Location
United States of AmericaLead Research Institution
Rho Federal Systems Division IncResearch Priority Alignment
N/A
Research Category
13
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Not applicable
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
PROJECT SUMMARY / ABSTRACTTo meet the challenge of the COVID-19 pandemic, Boston Children's Hospital (BCH) requested and received an administrative supplement to NIAID grant U19AI118608 "Ontogeny of Human Vaccine Responses" to fundthe Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC) Clinical and Data Coordinating Center(CDCC). The IMPACC study is an observational cohort collecting detailed clinical, laboratory, and radiographicdata in coordination with biologic sampling of blood and respiratory secretions and viral shedding in nasalsecretions in order to identify immunophenotypic and genomic features of COVID-19-related susceptibilityand/or progression in order to generate hypotheses for effective host-directed therapeutic interventions, to helpto prioritize proposals for such interventions, and/or optimize timing for administration of host-responsedirected therapeutics.Many sites in the IMPACC study lacked sufficient PPE to protect all study site staff interacting with hospitalizedCOVID-19 patients. Therefore, the IMPACC CDCC sought additional resources to distribute to the participatingsites. RhoFED responded to this need by procuring the necessary additional PPE, which consisted of masks,masks with eye shields, gowns, gloves, and face shields.